Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1978-08-03
1980-08-12
Demers, Arthur P.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
260561B, 260562A, 424308, 424311, 424314, 424324, 260107, A61K 3124, C07C10338
Patent
active
042173620
ABSTRACT:
Anilide derivative compounds of the formula ##STR1## e.g., trans-N-(2-hydroxycyclopentyl)-3',4'-dichloropropionanilide, have been found to possess potent Central Nervous System (CNS) antidepressant properties.
These compounds are promising antidepressant drugs which are characterized by less toxicity than imipramine, and long-acting activity which may allow longer durations between administrations, e.g., once a day. Pharmaceutical compositions containing these compounds and a process for treating conditions of depression with these compositions are also disclosed.
REFERENCES:
patent: 3510492 (1970-05-01), Szmuszkovicz
patent: 3852058 (1974-12-01), Huffman
patent: 4098904 (1978-07-01), Szmuszkovicz
Gordon et al., The Chemists Companion, J. Wiley & Sons, N.Y., N.Y., 1972, pp. 144-155.
Demers Arthur P.
Reynolds John T.
The Upjohn Company
LandOfFree
Anilide derivatives as antidepressants does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anilide derivatives as antidepressants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anilide derivatives as antidepressants will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2182605